• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Denali Therap(DNLI.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan9
Denali Therapeutics Executives Engage in Internal Stock Sales
02:52
Jan7
Jefferies Maintains Buy Rating on Denali Therapeutics
13:47
Jan6
Denali Therapeutics Inc. Reports Cash Reserves and Raises Funds
13:03
Dec30
Denali Therapeutics Reports Positive Clinical Trial Results for Hunter Syndrome Treatment tividenofusp alfa
13:00
Dec10
Denali Therapeutics Floats IPO to Raise $200 Million
23:42
Dec4
Denali Therapeutics and Royalty Pharma Reach $275 Million Financing Agreement
12:02

Schedules & Filings

Schedules
Filings
Dec30
Distribution Plan(EST)

Cash dividend 0.4302 USD, Cash dividend 0.1486 USD

Distribution Plan(EST)

Cash dividend 0.4302 USD, Cash dividend 0.1486 USD

Dec29
Distribution Plan(EST)

Cash dividend 0.4302 USD, Cash dividend 0.1486 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
86.850
+258.88%
+62.650
NBY
19.160
+102.54%
+9.700
VLN
2.480
+58.97%
+0.920
GP
1.240
+51.04%
+0.419
ATGL
30.610
+46.96%
+9.781
OPAD
2.190
+44.08%
+0.670
VCIG
0.9601
+41.00%
+0.279
THH
29.470
+36.31%
+7.850
APLX
113.630
+35.44%
+29.730
ZNTL
3.740
+31.69%
+0.900
View More